“I don't understand why a BP woul not take a share position in RVX now with the debt payment coming up.

If I were a BP and wanted some inexpensive shares of a company that was about to deliver Phase 3 trial results and possibly have to sepend billions of dollars to buy the company,... why not buy a few million shares now for next to nothing and reduce the overall price considerably.” Cabel

Where in this message does he specify open market?

In the past, RVX has sold shares to pharma in PP’s. There is no reason that cannot happen again now.

Assumptions don’t do us any good.

As for apologies, all the old timers can recall you arguing that RVX’s next trial after ASSURE would not be a sanctioned Phase 3 trial. You ate crow instead of loading up on sub $1 shares.

Perhaps you should consider limiting your comments to the Zenith board as you apparently have no holdings in RVX currently.

bfw